Handelsbanken Fonder’s Travere Therapeutics TVTX Stock Holding History

Handelsbanken Fonder’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Buy	+37,000	New	+$1.64M	0.01%	793
2023 Q4	–	Sell	-16,200	Closed	-$145K	–	1604
2023 Q3	$145K	Hold	16,200	–	–	﹤0.01%	1518
2023 Q2	$249K	Buy	16,200 +5,700	+54%	+$104K	﹤0.01%	1420
2023 Q1	$236K	Hold	10,500	–	–	﹤0.01%	1397
2022 Q4	$221K	Buy	10,500 +100	+1%	+$2.12K	﹤0.01%	1393
2022 Q3	$256K	Hold	10,400	–	–	﹤0.01%	1334
2022 Q2	$252K	Hold	10,400	–	–	﹤0.01%	1419
2022 Q1	$268K	Sell	10,400 -4,600	-31%	-$122K	﹤0.01%	1562
2021 Q4	$466K	Buy	+15,000	New	+$422K	﹤0.01%	1399
2019 Q3	–	Sell	-612,856	Closed	-$12.3M	–	194
2019 Q2	$12.3M	Buy	612,856 +150,000	+32%	+$2.96M	0.23%	116
2019 Q1	$10.5M	Buy	462,856 +18,940	+4%	+$419K	0.2%	120
2018 Q4	$10M	Buy	443,916 +176,916	+66%	+$4.4M	0.2%	122
2018 Q3	$7.67M	Buy	267,000 +102,000	+62%	+$2.92M	0.14%	138
2018 Q2	$4.5M	Buy	+165,000	New	+$4.39M	0.09%	149

Other funds holding TVTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder's TVTX Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 37,000 shares worth $2.1M. The stake represents 0.01% of the portfolio and ranks #793 among its holdings. This is a return to the name: Handelsbanken Fonder previously reported a position in TVTX as recently as Q3 2023.

Handelsbanken Fonder first reported a position in TVTX in Q2 2018 and has held it in 14 quarters since. The position peaked at $12.3M in Q2 2019. 121 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Handelsbanken Fonder held 37,000 shares of Travere Therapeutics worth $2.1M as of Q2 2026.
Travere Therapeutics was a new Handelsbanken Fonder position in Q2 2026.
Travere Therapeutics made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #793 holding.
Handelsbanken Fonder first reported a position in Travere Therapeutics in Q2 2018 and has held it in 14 quarters since.
Handelsbanken Fonder's Travere Therapeutics position peaked at $12.3M in Q2 2019.
121 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.